377 related articles for article (PubMed ID: 16245220)
1. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
[TBL] [Abstract][Full Text] [Related]
2. A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid.
Santos VN; Lanzoni VP; Szejnfeld J; Shigueoka D; Parise ER
Braz J Med Biol Res; 2003 Jun; 36(6):723-9. PubMed ID: 12792701
[TBL] [Abstract][Full Text] [Related]
3. Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomized controlled trial in 170 patients.
Tsubota A; Kumada H; Arase Y; Chayama K; Saitoh S; Ikeda K; Kobayashi M; Suzuki Y; Murashima N
Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1077-83. PubMed ID: 10524635
[TBL] [Abstract][Full Text] [Related]
4. Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis.
Dufour JF; Oneta CM; Gonvers JJ; Bihl F; Cerny A; Cereda JM; Zala JF; Helbling B; Steuerwald M; Zimmermann A;
Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1537-43. PubMed ID: 17162245
[TBL] [Abstract][Full Text] [Related]
5. A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.
Omata M; Yoshida H; Toyota J; Tomita E; Nishiguchi S; Hayashi N; Iino S; Makino I; Okita K; Toda G; Tanikawa K; Kumada H;
Gut; 2007 Dec; 56(12):1747-53. PubMed ID: 17573387
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study.
Lavine JE
J Pediatr; 2000 Jun; 136(6):734-8. PubMed ID: 10839868
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study.
Laurin J; Lindor KD; Crippin JS; Gossard A; Gores GJ; Ludwig J; Rakela J; McGill DB
Hepatology; 1996 Jun; 23(6):1464-7. PubMed ID: 8675165
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid for nonalcoholic steatohepatitis.
Wu SD; Li L; Wang JY
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1247-53. PubMed ID: 22864259
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid and artesunate in the treatment of severe falciparum malaria patients with jaundice.
Treeprasertsuk S; Silachamroon U; Krudsood S; Huntrup A; Suwannakudt P; Vannaphan S; Wilairatana P
J Gastroenterol Hepatol; 2010 Feb; 25(2):362-8. PubMed ID: 19817958
[TBL] [Abstract][Full Text] [Related]
10. COMPARATIVE ANALYSIS OF EFFICIENCY OF URSODEOXYCHOLIC ACID AND COMBINATION OF VITAMIN E AND VITAMIN C IN TREATMENT OF NON-DIABETIC NONALCOHOLIC STEATOHEPATITIS.
Barbakadze G; Khachidze T; Sulaberidze G; Burnadze K; Jebashvili M
Georgian Med News; 2019 Mar; (288):81-85. PubMed ID: 31101782
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
Bugianesi E; Gentilcore E; Manini R; Natale S; Vanni E; Villanova N; David E; Rizzetto M; Marchesini G
Am J Gastroenterol; 2005 May; 100(5):1082-90. PubMed ID: 15842582
[TBL] [Abstract][Full Text] [Related]
12. Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
Cadranel JF; Di Martino V; Dorent R; Bernard B; Hoang C; Myara A; Pauwels A; Ghoussoub JJ; Perrin M; Grippon P; Thabut D; Trivin F; Huraux JM; Gandjbakhch I; Opolon P; Lunel F
Transplantation; 2003 Apr; 75(7):977-82. PubMed ID: 12698083
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
Lindor KD; Kowdley KV; Heathcote EJ; Harrison ME; Jorgensen R; Angulo P; Lymp JF; Burgart L; Colin P
Hepatology; 2004 Mar; 39(3):770-8. PubMed ID: 14999696
[TBL] [Abstract][Full Text] [Related]
14. Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary cirrhosis: a 2-year follow-up study.
Zhu J; Shi Y; Zhou X; Li Z; Huang X; Han Z; Wang J; Wang R; Ding J; Wu K; Han Y; Fan D
Front Med; 2013 Jun; 7(2):255-63. PubMed ID: 23179137
[TBL] [Abstract][Full Text] [Related]
15. An open-label randomized control study to compare the efficacy of vitamin e versus ursodeoxycholic acid in nondiabetic and noncirrhotic Indian NAFLD patients.
Parikh P; Ingle M; Patel J; Bhate P; Pandey V; Sawant P
Saudi J Gastroenterol; 2016; 22(3):192-7. PubMed ID: 27184636
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients.
Fouda A; Abdelaziz AE; Hussien M; Ali AA; Abdelkawy KS; Elbarbry F
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7449-7459. PubMed ID: 34919247
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis.
Harrison SA; Torgerson S; Hayashi P; Ward J; Schenker S
Am J Gastroenterol; 2003 Nov; 98(11):2485-90. PubMed ID: 14638353
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.
Lirussi F; Beccarello A; Bortolato L; Morselli-Labate AM; Crovatto M; Ceselli S; Santini G; Crepaldi G
Liver; 1999 Oct; 19(5):381-8. PubMed ID: 10533795
[TBL] [Abstract][Full Text] [Related]
19. Therapy for nonalcoholic fatty liver disease.
Moseley RH
J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
[No Abstract] [Full Text] [Related]
20. Antioxidant supplementation attenuates oxidative stress in chronic hepatitis C patients.
Farias MS; Budni P; Ribeiro CM; Parisotto EB; Santos CE; Dias JF; Dalmarco EM; Fröde TS; Pedrosa RC; Wilhelm Filho D
Gastroenterol Hepatol; 2012; 35(6):386-94. PubMed ID: 22608494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
